About Blueprint Medicines
Blueprint Medicines is a company committed to the development and commercialization of precision therapies for people with genomically-defined cancers and hematological disorders. A focus of our clinical development efforts is on addressing the unmet need in indolent systemic mastocytosis. The PIONEER clinical trial (NCT03731260) is a phase 2, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of avapritinib + best supportive care (BSC) with placebo + BSC in patients with indolent systemic mastocytosis whose symptoms are not adequately controlled by BSC. This study is currently open and enrolling eligible patients at multiple centers across the United States and globally.
Blueprint Medicines and associated logo are trademarks of Blueprint Medicines Corporation.
© 2021 Blueprint Medicines Corporation.
05/2021 US-BP-MED-AVAASM-21019
Representatives
Ali Nagle, PhD
Medical Science Liaison – Associate Director
PA, Upstate NY, NJ, DE
anagle@blueprintmedicines.com
Blueprint Medicines Medical Information
medinfo@blueprintmedicines.com
1-888-BLU-PRNT (1-888-258-7768)
Blueprint Medicines is a company committed to the development and commercialization of precision therapies for people with genomically-defined cancers and hematological disorders. A focus of our clinical development efforts is on addressing the unmet need in indolent systemic mastocytosis. The PIONEER clinical trial (NCT03731260) is a phase 2, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of avapritinib + best supportive care (BSC) with placebo + BSC in patients with indolent systemic mastocytosis whose symptoms are not adequately controlled by BSC. This study is currently open and enrolling eligible patients at multiple centers across the United States and globally.
Blueprint Medicines and associated logo are trademarks of Blueprint Medicines Corporation.
© 2021 Blueprint Medicines Corporation.
05/2021 US-BP-MED-AVAASM-21019
Representatives
Ali Nagle, PhD
Medical Science Liaison – Associate Director
PA, Upstate NY, NJ, DE
anagle@blueprintmedicines.com
Blueprint Medicines Medical Information
medinfo@blueprintmedicines.com
1-888-BLU-PRNT (1-888-258-7768)
Resources
Blueprint PIONEER Trial Card
Blueprint PIONEER Trial Card
